Acorda Therapeutics, Inc. Gains 39.42%
Tue, Oct 20, 2020 at 05:30 PM
Acorda Therapeutics, Inc. (ACOR:NASDAQ) jumped higher at $0.96, a gain of 39.4%. The stock appeared on our News Catalysts scanner on Fri 09 Oct 20 at 03:02 AM in the 'INVESTOR UPDATE' category. From Mon 05 Oct 20, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Fri 25 Sep 20 at $0.86 with a volume of 94M+, and its share price has been moving sideways in recent weeks.
About Acorda Therapeutics, Inc. (ACOR:NASDAQ)
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.
Top 10 Gainers:
- Weidai Ltd. (WEI:NYSE), 526.45%
- X Financial (XYF:NYSE), 75.88%
- Dragon Victory International Limited (LYL:NASDAQ), 47.64%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 46.08%
- Jupai Holdings Limited (JP:NYSE), 42.69%
- Molecular Data Inc. (MKD:NASDAQ), 41.82%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 39.42%
- China Index Holdings Limited (CIH:NASDAQ), 35.71%
- Iterum Therapeutics plc (ITRM:NASDAQ), 35.29%
- Drive Shack Inc. (DS:NYSE), 31.62%